Due to an abundance of this aromatase-expressing tissue, obese postmenopausal women typically have higher levels of circulating estradiol [13-15], and researchers have posited that this may contribute to the observed increase in breast cancer risk and worse outcome in this population. This evidence concerns the gene CYP19A1 and breast carcinoma.